Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nesiritide citrate (Scios).

P Light1

  • 1Department of Physiology and Biophysics, University of Calgary, Alberta, Canada. plight@acs.ucalgary.ca

Idrugs : the Investigational Drugs Journal
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study.

Diabetic medicine : a journal of the British Diabetic Association·2016
Same author

Electromagnetically-induced transparency grid in acetylene-filled hollow-core PCF.

Optics express·2009
Same author

Pamicogrel (Kanebo).

IDrugs : the investigational drugs journal·2005
Same author

Azimilide (Procter & Gamble).

IDrugs : the investigational drugs journal·2005
Same author

Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers.

Kidney international·2001
Same author

A prospective study of vascular access infections at seven outpatient hemodialysis centers.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2001

Nesiritide citrate, a novel human brain natriuretic peptide, is being developed for congestive heart failure (CHF). Further research suggests potential applications in managing surgical hypertension.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Nesiritide citrate is a synthetic form of human brain natriuretic peptide.
  • Congestive heart failure (CHF) remains a significant cardiovascular disease with unmet treatment needs.

Purpose of the Study:

  • To evaluate the potential of nesiritide citrate for treating congestive heart failure (CHF).
  • To explore the efficacy of human brain natriuretic peptide in managing acute hypertension during surgical procedures.

Main Methods:

  • The development of nesiritide citrate by Scios.
  • Submission of a New Drug Application (NDA) to the US FDA for short-term CHF treatment.
  • Conducting animal studies to assess efficacy in hypertension management.

Main Results:

Related Experiment Videos

  • An NDA for nesiritide citrate for short-term CHF was submitted to the US FDA in April 1998.
  • Animal studies indicate potential utility in managing surgical acute hypertension.
  • Scios anticipates a mid-1999 product launch.

    • Conclusions:

    • Nesiritide citrate shows promise as a therapeutic agent for congestive heart failure.
    • Human brain natriuretic peptide may offer a new approach to managing perioperative hypertension.